SUNRISE” has 11 authors: Lead author is PPHM’s Nikoletta L.Kallinteris, and Senior Author is PerkinElmer’s Technology Strategist Cliff Hoyt, whose function at PKI is to "help identify clinical opportunities that can be addressed through new technologies & capabilities, including forming collaborations & partnerships with academic & industrial institutions.”
Some info arriving and anyone know the background for THP Turner Hill Partners (Akoya / Agena Bioscience etc etc) that had ties with Cellular Dynanics International and Perkin Elmer bought out by Akoya for those Biomarkers
25-50 protein Biomarkers were fully derived out of Sunrise
Cliff Hoyt not responding to questions and this entire story keeps becoming exposed as exosomes require certain protein pathway Biomarkers and many a medical device need the IP that Stafford knew about
thanks for tying some other puzzle pieces together that I did not see till now
Market Data 
Markets 
AI
